Evidence map›Paper›PMID 27617186›Full record

ArticleCurrent pharmacology reports2016

Progress and prospects of reactive oxygen species in metal carcinogenesis.

Lei Wang, James T F Wise, Zhuo Zhang, Xianglin Shi

Open access · bronzeAbstract read
In one paragraph

Article in Current pharmacology reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Impact of Heavy Metals on Glioma Tumorigenesis.International journal of molecular sciences · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lei WangCenter for Research on Environmental Disease, College of Medicine, University of Kentucky, Lexington, KY 40536, USA; Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY 40536, USA.
James T F WisePharmacology and Nutritional Sciences, College of Medicine, University of Kentucky, Lexington, KY 40536, USA.
Zhuo ZhangToxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY 40536, USA.
Xianglin ShiCenter for Research on Environmental Disease, College of Medicine, University of Kentucky, Lexington, KY 40536, USA; Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY 40536, USA.
University of Kentucky · US

Funding

Oxidative stress, Cr(VI) carcinogenesis, and preventionR01ES025515 · NIEHS · UNIVERSITY OF KENTUCKY · PI SHI, XIANGLIN, ZHANG, ZHUO · 2015 to 2019
$2.9M
Apoptosis resistance and Cr(VI) carcinogenesisR01ES021771 · NIEHS · UNIVERSITY OF KENTUCKY · PI SHI, XIANGLIN, ZHANG, ZHUO · 2014 to 2018
$1.7M
Prevention of UV-induced carcinogenesis by cyanidin-3-glucosideR01ES017244 · NIEHS · UNIVERSITY OF KENTUCKY · PI SHI, XIANGLIN · 2011 to 2015
$1.7M
Cell survival and arsenic carcinogenesisR01ES020870 · NIEHS · UNIVERSITY OF KENTUCKY · PI SHI, XIANGLIN · 2012 to 2016
$1.7M
NIEHS NIH HHS R01 ES017244NIEHS NIH HHS R01 ES020870NIEHS NIH HHS R01 ES021771NIEHS NIH HHS R01 ES025515
6 · The paper itself

Abstract

Carcinogenesis induced by environmental metal exposure is a major public health concern. The exact mechanisms underlying metal carcinogenesis remain elusive. In the past few decades, the relationship between metal induced generation of reactive oxygen species (ROS) and the mechanism of metal carcinogenesis has been established. The carcinogenic process is a very complex one. In the early stage of metal carcinogenesis or cell transformation high levels of ROS are oncogenic by causing DNA damage, genetic instability, epigenetic alteration, and metabolic reprogramming, leading to malignant transformation. In the second stage of metal carcinogenesis or the cancer development of metal-transformed cells, low levels of ROS are carcinogenic by promoting apoptosis resistance. The metal-transformed cells have the property of autophagy deficiency, resulting in accumulation of p62 and constitutive activation of Nrf2, and leading to higher levels of antioxidants, decreased levels of ROS, apoptosis resistance, inflammation, and angiogenesis. This review summarizes the most recent development in the field of metal carcinogenesis with emphasis on the difference in cellular events between early (cell transformation) and late (after cell transformation) stages of metal carcinogenesis.

Indexed as

carcinogenesismetalNrf2reactive oxygen species (ROS)tumorigenesis

Identifiers

PMID27617186
PMCPMC5015764
OpenAlexW2340793520

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.